PC
OGN icon

PointState Capital’s Organon & Co OGN Stock Holding History

PointState Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-315,000
Closed -$10.3M – 159
2021
Q3 		$10.3M Sell
315,000
-38,000
-11% -$1.22M 0.17% 78
2021
Q2 		$10.7M Buy
+353,000
New +$11.6M 0.18% 75

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PointState Capital's OGN Position: Q4 2021 in Review

PointState Capital sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 315,000 shares — an estimated $10.3M sold.

PointState Capital first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $10.7M in Q2 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

  • PointState Capital reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
  • PointState Capital sold 315,000 Organon & Co shares in Q4 2021, an estimated $10.3M.
  • PointState Capital first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
  • PointState Capital's Organon & Co position peaked at $10.7M in Q2 2021.
  • 907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on PointState Capital's 13F filing for Q4 2021, filed 11 Feb 2022.